Radiant Research has joined with Synexus to form a global site network of 185 sites. This creates the world's largest and most patient focused site network, spanning 11 countries and offering access t...
Radiant Research has joined with Synexus to form a global site network of 185 sites. This creates the world's largest and most patient focused site network, spanning 11 countries and offering access to more than 100 million patients in key clinical development markets, operating under the Synexus name. Together we offer data driven site selection and activation that is combined with proven patient engagement expertise across the US, Europe & Africa. Synexus is a unique company that excels in the identification, recruitment and retention of patients for clinical trials, on behalf of a number of leading pharmaceutical, biotechnology and contract research organisations (CRO's): Together for the future of health. Founded in 1992 Synexus operates a network of 27 dedicated research centres including the UK, Germany, Poland, Hungary, Romania, Bulgaria, Ukraine and South Africa, enabling us to access a population of over 79 million potential patients on behalf of our clients. In addition, we have a network of 60+ complementary affiliated sites which further increase our access to patients. Synexus supports clinical trials through phases II-IV and specializes in five key therapeutic areas – cardiovascular, musculoskeletal, respiratory, endocrinology/metabolic and central nervous system. Working in support of our clients, we manage over 200 trials and thousands of patients at any one time, utilizing our scale to deliver cost advantages and to improve speed to market for new in-patent drugs. Synexus is the patient's choice for clinical research. By putting patients first and ensuring patient engagement, Synexus consistently delivers exceptional service.